138 related articles for article (PubMed ID: 32179199)
1. Integrative findings indicate anti-tumor biotargets and molecular mechanisms of calycosin against osteosarcoma.
Tan J; Qin X; Liu B; Mo H; Wu Z; Yuan Z
Biomed Pharmacother; 2020 Jun; 126():110096. PubMed ID: 32179199
[TBL] [Abstract][Full Text] [Related]
2. Anticancer targets and mechanisms of calycosin to treat nasopharyngeal carcinoma.
Liu F; Pan Q; Wang L; Yi S; Liu P; Huang W
Biofactors; 2020 Jul; 46(4):675-684. PubMed ID: 32449282
[TBL] [Abstract][Full Text] [Related]
3. Clinical case report of patients with osteosarcoma and anticancer benefit of calycosin against human osteosarcoma cells.
Qiu R; Ma G; Li X; Shi Q; Li X; Zhou X; Tang Y; Xie Z; Liao S; Qin Y; Wang R; Ye Y; Luo J; Zhang J
J Cell Biochem; 2019 Jun; 120(6):10697-10706. PubMed ID: 30652346
[TBL] [Abstract][Full Text] [Related]
4. Anti-neoplastic characteristics and potential targets of calycosin against bisphenol A-related osteosarcoma: bioinformatics analysis.
Pan Q; Wu K; Tan J; Li Y; Liang X; Su M
Bioengineered; 2021 Dec; 12(1):4278-4288. PubMed ID: 34311656
[TBL] [Abstract][Full Text] [Related]
5. Antineoplastic effect of calycosin on osteosarcoma through inducing apoptosis showing in vitro and in vivo investigations.
Qiu R; Ma G; Zheng C; Qiu X; Li X; Li X; Mo J; Li Z; Liu Y; Mo L; Bi G; Ye Y
Exp Mol Pathol; 2014 Aug; 97(1):17-22. PubMed ID: 24797937
[TBL] [Abstract][Full Text] [Related]
6. Anti-cancer targets of formononetin and molecular mechanisms in osteosarcoma: Findings of bioinformatic and experimental assays.
Hu W; Wu X; Tang J; Zhao G; Xiao N; Zhang L; Li S
J Cell Mol Med; 2019 May; 23(5):3505-3511. PubMed ID: 30873755
[TBL] [Abstract][Full Text] [Related]
7. Calycosin, a Phytoestrogen Isoflavone, Induces Apoptosis of Estrogen Receptor-Positive MG-63 Osteosarcoma Cells via the Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
Sun H; Yin M; Qian W; Yin H
Med Sci Monit; 2018 Sep; 24():6178-6186. PubMed ID: 30182951
[TBL] [Abstract][Full Text] [Related]
8. Antimetastatic effects of calycosin on osteosarcoma and the underlying mechanism.
Qiu R; Li X; Qin K; Chen X; Wang R; Dai Y; Deng L; Ye Y
Biofactors; 2019 Nov; 45(6):975-982. PubMed ID: 31322783
[TBL] [Abstract][Full Text] [Related]
9. Calycosin induces apoptosis via p38‑MAPK pathway‑mediated activation of the mitochondrial apoptotic pathway in human osteosarcoma 143B cells.
Tian W; Wang ZW; Yuan BM; Bao YG
Mol Med Rep; 2020 Nov; 22(5):3962-3968. PubMed ID: 32901836
[TBL] [Abstract][Full Text] [Related]
10. Calycosin induces apoptosis in osteosarcoma cell line via ERβ‑mediated PI3K/Akt signaling pathways.
Tian W; Wang ZW; Yuan BM; Bao YG
Mol Med Rep; 2020 Jun; 21(6):2349-2356. PubMed ID: 32236598
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatic and biochemical findings disclosed anti-hepatic steatosis mechanism of calycosin.
Cheng X; Liu N; Liu H; Huang N; Sun X; Zhang G
Bioorg Chem; 2020 Jul; 100():103914. PubMed ID: 32417523
[TBL] [Abstract][Full Text] [Related]
12. Honokiol suppresses proliferation and induces apoptosis via regulation of the miR‑21/PTEN/PI3K/AKT signaling pathway in human osteosarcoma cells.
Yang J; Zou Y; Jiang D
Int J Mol Med; 2018 Apr; 41(4):1845-1854. PubMed ID: 29393336
[TBL] [Abstract][Full Text] [Related]
13. Crude extract of Rheum palmatum L. Induces cell cycle arrest S phase and apoptosis through mitochondrial-dependent pathways in U-2 OS human osteosarcoma cells.
Lin CC; Lee MH; Lin JH; Lin ML; Chueh FS; Yu CC; Lin JP; Chou YC; Hsu SC; Chung JG
Environ Toxicol; 2016 Aug; 31(8):957-69. PubMed ID: 25689151
[TBL] [Abstract][Full Text] [Related]
14. Discovery of the Anti-Tumor Mechanism of Calycosin Against Colorectal Cancer by Using System Pharmacology Approach.
Huang C; Li R; Shi W; Huang Z
Med Sci Monit; 2019 Jul; 25():5589-5593. PubMed ID: 31352466
[TBL] [Abstract][Full Text] [Related]
15. Licochalcone A-Induced Apoptosis Through the Activation of p38MAPK Pathway Mediated Mitochondrial Pathways of Apoptosis in Human Osteosarcoma Cells In Vitro and In Vivo.
Lin RC; Yang SF; Chiou HL; Hsieh SC; Wen SH; Lu KH; Hsieh YH
Cells; 2019 Nov; 8(11):. PubMed ID: 31739642
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological targets and molecular mechanisms of plumbagin to treat colorectal cancer: A systematic pharmacology study.
Liang Y; Zhou R; Liang X; Kong X; Yang B
Eur J Pharmacol; 2020 Aug; 881():173227. PubMed ID: 32505664
[TBL] [Abstract][Full Text] [Related]
17. Long Non-Coding RNA TUG1 Promotes Proliferation and Inhibits Apoptosis of Osteosarcoma Cells by Sponging miR-132-3p and Upregulating SOX4 Expression.
Li G; Liu K; Du X
Yonsei Med J; 2018 Mar; 59(2):226-235. PubMed ID: 29436190
[TBL] [Abstract][Full Text] [Related]
18. Let-7d miRNA Shows Both Antioncogenic and Oncogenic Functions in Osteosarcoma-Derived 3AB-OS Cancer Stem Cells.
Di Fiore R; Drago-Ferrante R; Pentimalli F; Di Marzo D; Forte IM; Carlisi D; De Blasio A; Tesoriere G; Giordano A; Vento R
J Cell Physiol; 2016 Aug; 231(8):1832-41. PubMed ID: 26679758
[TBL] [Abstract][Full Text] [Related]
19. Gadolinium chloride elicits apoptosis in human osteosarcoma U-2 OS cells through extrinsic signaling, intrinsic pathway and endoplasmic reticulum stress.
Tsai YF; Huang CW; Chiang JH; Tsai FJ; Hsu YM; Lu CC; Hsiao CY; Yang JS
Oncol Rep; 2016 Dec; 36(6):3421-3426. PubMed ID: 27748868
[TBL] [Abstract][Full Text] [Related]
20. Theabrownin triggers DNA damage to suppress human osteosarcoma U2OS cells by activating p53 signalling pathway.
Jin W; Zhou L; Yan B; Yan L; Liu F; Tong P; Yu W; Dong X; Xie L; Zhang J; Xu Y; Li C; Yuan Q; Shan L; Efferth T
J Cell Mol Med; 2018 Sep; 22(9):4423-4436. PubMed ID: 29993186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
